CSPG4P4Y

Across TCGA pan-cancer cohorts, CSPG4P4Y RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated CSPG4P4Y data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CSPG4P4Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CSPG4P4Y expression acts as an unfavorable survival marker.

KIRP, HNSC, and UCEC are the cancer types where CSPG4P4Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.216	0.904	<.001	45	view →
HNSC	OS	Tertile	All	0.520	0.771	.003	42	view →
UCEC	OS	Tertile	All	0.599	0.873	.039	18	view →
SKCM	OS	Tertile	II,III,IV	0.646	0.850	.013	15	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CSPG4P4Y–KIRP (OS)

Open the KIRP breakdown →